FOI Request Public Health Spend and Distribution
1. Please provide a summary breakdown of the public health spend for Moray in each of the last 5 years (2013-2017 inclusive).
• I’m interested in receiving a detailed account of the public health spend of Moray, and more specifically how the public health spend was distributed across the different services it covers for the period indicated above.
2. Please provide a summary breakdown of the Sexual and Reproductive Health (SRH) spend of Moray was distributed in each of the last 5 years (2013-2017 inclusive).
• My understanding is that SRH spend covers a range of services including, but not exclusively, contraception provision and advice, sexual health treatment and advice, pregnancy related care, abortion related care, cervical screening, psychosexual therapy, PMS treatment, colposcopy services, fertility treatment and care and gynaecological treatment and care. I’m interested in receiving detailed outline of the spend of Moray for each of these services for the period indicated above.
3. Please provide a breakdown of the spend for sexual health treatment and advice in each of the last five years (2013-2017 inclusive).
• I would like to receive a detailed account of the spend of Moray within the sexual health treatment and advice service area specifically. I’m looking for an outline of the specific services provided and the associated spend for each service.
4. What was the total spend on chlamydia screening in Moray in each of the last 5 years (2013-2017 inclusive)?
5. To the best of your knowledge, are you budgeting more or less spending on chlamydia testing for future years?
6. Has Moray met the PHE recommendation of an annual diagnosis rate of at least 2,300 per 100,000 15-24 year olds per year in each of the last 5 years (2013-2017 inclusive)?
7. Has Moray met the PHE recommendation for providing integrated services by ensuring 70% of all chlamydia tests are delivered via primary care services (GP surgeries, community pharmacies), SRH services (including abortion providers) or GUM services?
8. What have been the biggest challenges for Moray in reaching the National Chlamydia Screening Target? (e.g. budget, marketing)
9. Thinking about chlamydia screening and treatment specifically, what resources does Moray needs the most to effectively control chlamydia through early detection and treatment of the infection? (e.g. budget, technical resources, staff, marketing)